Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture

被引:105
作者
Francque, Sven [1 ,2 ]
Laleman, Wim [3 ]
Verbeke, Len [3 ]
Van Steenkiste, Christophe [4 ]
Casteleyn, Christophe [5 ]
Kwanten, Wilhelmus [2 ]
Van Dyck, Christophe [2 ]
D'Hondt, Michiel [2 ]
Ramon, Albert [1 ,6 ,7 ]
Vermeulen, Wim [2 ]
De Winter, Benedicte [2 ]
Van Marck, Eric [8 ]
Van Marck, Veerle [8 ]
Pelckmans, Paul [1 ,2 ]
Michielsen, Peter [1 ,2 ]
机构
[1] Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium
[2] Univ Antwerp, Fac Med, Div Gastroenterol, Lab Expt Med & Paediat, B-2020 Antwerp, Belgium
[3] Univ Hosp Gasthuisberg, Dept Hepatol, B-3000 Louvain, Belgium
[4] Ghent Univ Hosp, Dept Hepatol, Ghent, Belgium
[5] Univ Ghent, Fac Vet Med, Dept Morphol, B-9000 Ghent, Belgium
[6] ITERA Int Tissue Engn Res Assoc Life Sci Forum, Lanaken, Belgium
[7] Genet Diagnost Labor, Cologne, Germany
[8] Univ Antwerp, Fac Med, Pathol Lab, B-2020 Antwerp, Belgium
关键词
endothelial dysfunction; in situ perfusion; intrahepatic resistance; morphological alterations; NAFLD; portal hypertension; FATTY LIVER-DISEASE; CIRRHOTIC RAT LIVERS; PORTAL-HYPERTENSION; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; NITRIC-OXIDE; METABOLIC SYNDROME; ANIMAL-MODELS; MICROCIRCULATION; ANGIOGENESIS;
D O I
10.1038/labinvest.2012.103
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-alcoholic fatty liver disease can progress to steatohepatitis and fibrosis, and is also associated with impaired liver regeneration. The pathophysiology remains elusive. We recently showed that severe steatosis is associated with an increase in portal pressure, suggesting liver flow impairment. The objective of this study is to directly assess total intrahepatic resistance and its potential functional and structural determinants in an in situ perfusion model. Male Wistar rats fed a control (n=30) or a methionine choline-deficient (MCD) diet (n=30) for 4 weeks were compared. Liver tissue and serum analysis, in vivo haemodynamic measurements, in situ perfusion experiments and vascular corrosion casts were performed. The MCD group showed severe steatosis without inflammation or fibrosis on histology. Serum levels and liver tissue gene expression of interleukin (IL)-6, tumour necrosis factor-alpha IL-1 beta and interferon-gamma, liver tissue myeloperoxidase activity and liver immunohistochemistry with anti-CD68 and anti-alpha smooth muscle actin were comparable between groups, excluding significant inflammation. Flow-pressure curves were significantly different between groups for all flows (slope values: 0.1636 +/- 0.0605 mm Hg/ml/min in controls vs 0.7270 +/- 0.0408 mm Hg/ml/min in MCD-fed rats, P<0.001), indicating an increased intrahepatic resistance, which was haemodynamically significant (portocaval pressure gradient 2.2 +/- 1.1 vs 8.2 +/- 1.3 mm Hg in controls vs MCD, P<0.001). Dose-response curves to acetylcholine were significantly reduced in MCD-fed rats (P<0.001) as was the responsiveness to methoxamine (P<0.001). Vascular corrosion casts showed a replacement of the regular sinusoidal anatomy by a disorganized pattern with multiple interconnections and vascular extensions. Liver phosphorylated endothelial NO synthase (eNOS)/eNOS and serum nitrite/nitrate were not increased in severe steatosis, whereas liver thromboxane synthase expression, liver endothelin-1 (ET-1) expression and serum andothelin-1 concentration were significantly increased. Severe steatosis induces a haemodynamically significant increase in intrahepatic resistance, which precedes inflammation and fibrogenesis. Both functional (endothelial dysfunction and increased thromboxane and ET-1 synthesis) and structural factors are involved. This phenomenon might significantly contribute to steatosis-related disease. Laboratory Investigation (2012) 92, 1428-1439; doi:10.1038/labinvest.2012.103; published online 13 August 2012
引用
收藏
页码:1428 / 1439
页数:12
相关论文
共 45 条
[1]   The endothelium: physiological functions and role in microcirculatory failure during severe sepsis [J].
Ait-Oufella, H. ;
Maury, E. ;
Lehoux, S. ;
Guidet, B. ;
Offenstadt, G. .
INTENSIVE CARE MEDICINE, 2010, 36 (08) :1286-1298
[2]   Endothelin: 20 years from discovery to therapy [J].
Barton, Matthias ;
Yanagisawa, Masashi .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2008, 86 (08) :485-498
[3]   Hepatic Steatosis as a Potential Risk Factor for Major Hepatic Resection [J].
Behrns K.E. ;
Tsiotos G.G. ;
DeSouza N.F. ;
Krishna M.K. ;
Ludwig J. ;
Nagorney D.M. .
Journal of Gastrointestinal Surgery, 1998, 2 (3) :292-298
[4]   The isolated perfused rat liver: standardization of a time-honoured model [J].
Bessems, M. ;
t'Hart, N. A. ;
Tolba, R. ;
Doorschodt, B. M. ;
D Leuvenink, H. G. ;
Ploeg, R. J. ;
Minor, T. ;
van Gulik, T. M. .
LABORATORY ANIMALS, 2006, 40 (03) :236-246
[5]  
Bradley P, 1978, AM J PHYSIOL-REG I, V234, pR72
[6]   Histopathology of Non-Alcoholic Fatty Liver Disease [J].
Brunt, Elizabeth M. .
CLINICS IN LIVER DISEASE, 2009, 13 (04) :533-+
[7]   Insulin resistance: A metabolic pathway to chronic liver disease [J].
Bugianesi, E ;
McCullough, AJ ;
Marchesini, G .
HEPATOLOGY, 2005, 42 (05) :987-1000
[8]   Clinical update on non-alcoholic fatty liver disease and steatohepatitis [J].
Bugianesi, Elisabetta ;
Bellentani, Stefano ;
Bedogni, Giorgio ;
Tiribelli, Claudio ;
Svegliati-Baroni, Gianluca ;
Croce, Lory S. ;
Gastaldelli, Amalia ;
Marchesini, Giulio ;
Marra, Fabio ;
Perseghin, Gianluca ;
Tell, Gianluca .
ANNALS OF HEPATOLOGY, 2008, 7 (02) :157-160
[9]   NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes [J].
Bugianesi E. ;
Vanni E. ;
Marchesini G. .
Current Diabetes Reports, 2007, 7 (3) :175-180
[10]   Validation of the murine aortic arch as a model to study human vascular diseases [J].
Casteleyn, Christophe ;
Trachet, Bram ;
Van Loo, Denis ;
Devos, Daniel G. H. ;
Van den Broeck, Wim ;
Simoens, Paul ;
Cornillie, Pieter .
JOURNAL OF ANATOMY, 2010, 216 (05) :563-571